Works matching IS 13518216 AND DT 2018 AND VI 24 AND IP 2

Results: 34

A brief survey of clinicians’ perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia.

Published in:

2018

By:

Lucier, K. J.;
Movilla, R. V.;
Parvizian, M. K.;
Siddiqui, R.;
Gabriele, E. H.;
Bourque, M.;
MacIsaac, J.;
Lane, S. J.;
Heddle, N. M.;
Moorehead, P. C.;
Chan, A. K.

Publication type:

Letter to the Editor

Pocket handheld ultrasound for evaluation of the bleeding haemophilic joint: A novel and reliable way to recognize joint effusions.

Published in:

2018

By:

Zhou, J. Y.;
Rappazzo, K. C.;
Volland, L.;
Barnes, R. F. W.;
Brackman, M.;
von Drygalski, A.;
Steiner, B.;
Kruse‐Jarres, R.;
Quon, D. V.;
Bailey, C.;
Chang, E. Y.

Publication type:

Letter to the Editor

Hepatitis C infection in a Greek population with inherited bleeding disorders.

Published in:

2018

By:

Giouleme, O.;
Paschos, P.;
Katsoula, A.;
Panteliadou, K.;
Vakalopoulou, S.;
Garipidou, V.

Publication type:

Letter to the Editor

Laboratory monitoring issues in recombinant porcine FVIII replacement in acquired haemophilia A.

Published in:

2018

By:

Vanguru, V. R.;
Konda, M.;
Chen, V. M.;
Kershaw, G.

Publication type:

Letter to the Editor

Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 186, doi. 10.1111/hae.13424

By:

Miller, C. H.

Publication type:

Article

A novel missense mutation, p.Phe360Cys, in FIX gene results in haemophilia B in a female patient with skewed X‐inactivation.

Published in:

2018

By:

Yang, C.;
Yu, Z.;
Zhang, W.;
Cao, L.;
Ouyang, W.;
Hu, F.;
Zhang, P.;
Bai, X.;
Ruan, C.

Publication type:

Letter to the Editor

Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 278, doi. 10.1111/hae.13419

By:

Khatri, N. V.;
Bull‐Henry, K.;
Kessler, C. M.;
Patel, B.;
Kohli, D. R.;
Solomon, S. S.

Publication type:

Article

Congenital bleeding disorders: Report from one tertiary centre in Guatemala.

Published in:

2018

By:

Oliva‐Lara, S. C.;
Vallejo‐McCarthy, N. A.;
Ortiz‐Ruiz, A. M.

Publication type:

Letter to the Editor

Successful delivery in an patient with afibrinogenemia after three abortions: A case report and review of the literature.

Published in:

2018

By:

Karimi, M.;
Bordbar, M.;
Bazrafshan, A.;
Aali, M.;
Tavoosi, H.;
Gerdabi, J.

Publication type:

Letter to the Editor

Management of brothers with haemophilia A and familial cerebral cavernous malformations.

Published in:

2018

By:

Zhang, Kevin J.;
Chitlur, M.

Publication type:

Letter to the Editor

Interpreting data on inhibitor development from previously untreated patient studies, beware of premature conclusions.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 177, doi. 10.1111/hae.13408

By:

Fischer, K.

Publication type:

Article

Pyogenic sacroiliitis and haemophilia—A duo not often considered.

Published in:

2018

By:

Alhucema, P.;
Furmedge, J.;
Campbell, S.;
Barnes, C.

Publication type:

Letter to the Editor

A golden age for Haemophilia treatment?

Published in:

2018

By:

Makris, M.;
Hermans, C.

Publication type:

Editorial

A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 236, doi. 10.1111/hae.13410

By:

Dubé, E.;
Bonnefoy, A.;
Merlen, C.;
Rivard, G.‐É.;
St‐Louis, J.;
Castilloux, J.‐F.;
Cloutier, S.;
Demers, C.;
Sabapathy, C. A.;
Vezina, C.;
Warner, M.

Publication type:

Article

First‐year results of an expanded humanitarian aid programme for haemophilia in resource‐constrained countries.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 229, doi. 10.1111/hae.13409

By:

Pierce, G. F.;
Haffar, A.;
Ampartzidis, G.;
Peyvandi, F.;
Diop, S.;
El‐Ekiaby, M.;
van den Berg, H. M.

Publication type:

Article

Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors—A retrospective analysis.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 245, doi. 10.1111/hae.13413

By:

Carcao, M.;
Morales‐Arias, J.;
Dumont, J.;
Tsao, E.;
Jain, N.;
Miyasato, G.;
Pipe, S. W.;
Shapiro, A.;
Staber, J. M.;
Hwang, N.;
Druzgal, C.;
Lieuw, K.;
Belletrutti, M.;
Thornburg, C. D.;
Ahuja, S. P.

Publication type:

Article

Spectrum and origin of mutations in sporadic cases of haemophilia A in China.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 291, doi. 10.1111/hae.13402

By:

Lu, Y.;
Dai, J.;
Wu, X.;
Ding, Q.;
Wu, W.;
Wang, X.;
Xin, Y.;
You, G.

Publication type:

Article

Discordant von Willebrand factor (VWF) activity in patients with <italic>VWF</italic> p.Gly1324Ser confirmed in vitro.

Published in:

2018

By:

Bowman, M.;
James, P.;
Rimmer, E.;
Houston, D. S.;
Israels, S. J.

Publication type:

Letter to the Editor

The role of sclerostin/dickkopf‐1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross‐sectional study.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 316, doi. 10.1111/hae.13384

By:

Anagnostis, P.;
Vakalopoulou, S.;
Garipidou, V.;
Christoulas, D.;
Papatheodorou, A.;
Paschou, S. A.;
Kokkoris, P.;
Terpos, E.

Publication type:

Article

After the SIPPET study: Position paper of the CoMETH, the French society of haemophilia.

Published in:

2018

By:

Lebreton, A.;
Castet, S.;
Falaise, C.;
Rugeri, L.;
Schved, J.‐F.;
Wibaut, B.

Publication type:

Letter to the Editor

Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 198, doi. 10.1111/hae.13396

By:

Favaloro, E. J.;
Lippi, G.

Publication type:

Article

Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 283, doi. 10.1111/hae.13387

By:

Platokouki, H.;
van den Berg, H. M.;
Fischer, K.;
Gouw, S. C.;
Rafowicz, A.;
Carcao, M.;
Kenet, G.;
Liesner, R.;
Kurnik, K.;
Rivard, G. E.

Publication type:

Article

Mid‐ to long‐term results of total ankle replacement in patients with haemophilic arthropathy: A 10‐year follow‐up.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 307, doi. 10.1111/hae.13386

By:

Eckers, F.;
Bauer, D. E.;
Hingsammer, A.;
Viehöfer, A.;
Wirth, S. H.;
Sutter, R.;
Brand, B.

Publication type:

Article

Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate<sup>®</sup>: Final report from a prospective study.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 221, doi. 10.1111/hae.13385

By:

Klukowska, A.;
Laguna, P.;
Komrska, V.;
Vdovin, V.;
Pavlova, A.;
Jansen, M.;
Lowndes, S.;
Belyanskaya, L.;
Walter, O.

Publication type:

Article

Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 271, doi. 10.1111/hae.13398

By:

Husseinzadeh, H.;
Kelty, M.;
Chiang, E.;
Fogarty, P. F.;
Cuker, A.;
Chiasakul, T.;
Gimotty, P. A.;
Pukenas, B.;
Wolf, R.

Publication type:

Article

Mid‐term outcomes and complications of total knee arthroplasty in haemophilic arthropathy: A review of consecutive 131 knees between 2006 and 2015 in a single institute.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 299, doi. 10.1111/hae.13383

By:

Song, S. J.;
Bae, J. K.;
Park, C. H.;
Yoo, M. C.;
Bae, D. K.;
Kim, K. I.

Publication type:

Article

Molecular investigation of 41 patients affected by coagulation factor XI deficiency.

Published in:

2018

By:

Rimoldi, V.;
Duga, S.;
Asselta, R.;
Paraboschi, E. M.;
Menegatti, M.;
Peyvandi, F.;
Salomon, O.

Publication type:

Letter to the Editor

Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 261, doi. 10.1111/hae.13377

By:

Kempton, C. L.;
Recht, M.;
Neff, A.;
Wang, M.;
Buckner, T. W.;
Soni, A.;
Quon, D.;
Witkop, M.;
Boggio, L.;
Gut, R. Z.;
Cooper, D. L.

Publication type:

Article

The spectrum of bleeding in women and girls with haemophilia B.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 180, doi. 10.1111/hae.13376

By:

Staber, J.;
Croteau, S. E.;
Davis, J.;
Grabowski, E. F.;
Kouides, P.;
Sidonio, Jr, R. F.

Publication type:

Article

Australian multicentre study of current real‐world prophylaxis practice in severe and moderate haemophilia A and B.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 253, doi. 10.1111/hae.13375

By:

Parikh, S.;
Mason, J. A.;
Rowell, J.;
McRae, S.;
Tran, H.

Publication type:

Article

Measuring activities and participation in persons with haemophilia: A systematic review of commonly used instruments.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. e33, doi. 10.1111/hae.13367

By:

Schutgens, R. E. G.;
Fischer, K.;
Timmer, M. A.;
de Kleijn, P.;
Pisters, M. F.;
Gouw, S. C.;
Zwagemaker, A.;
Feldman, B. M.;
Blanchette, V.;
Srivastava, A.;
David, J. A.;
van der Net, J.

Publication type:

Article

Issue Information.

Published in:: Haemophilia, 2018, v. 24, n. 2, p. 165, doi. 10.1111/hae.13335
Publication type:: Article

Instructions for Authors.

Published in:: Haemophilia, 2018, v. 24, n. 2, p. 323, doi. 10.1111/hae.13334
Publication type:: Article

Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study.

Published in:

Haemophilia, 2018, v. 24, n. 2, p. 211, doi. 10.1111/hae.13320

By:

Liesner, R. J.;
Dubey, L.;
Ducore, J.;
Fouzia, N. A.;
Gattens, M.;
Gruel, Y.;
Guillet, B.;
Kavardakova, N.;
El Khorassani, M.;
Klukowska, A.;
Lambert, T.;
Abashidze, M.;
Lohade, S.;
Sigaud, M.;
Turea, V.;
Wu, J. K. M.;
Vdovin, V.;
Pavlova, A.;
Jansen, M.;
Belyanskaya, L.

Publication type:

Article